These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 24778043)

  • 1. Novel serum nucleosomics biomarkers for the detection of colorectal cancer.
    Holdenrieder S; Dharuman Y; Standop J; Trimpop N; Herzog M; Hettwer K; Simon K; Uhlig S; Micallef J
    Anticancer Res; 2014 May; 34(5):2357-62. PubMed ID: 24778043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide identification and validation of a novel methylation biomarker, SDC2, for blood-based detection of colorectal cancer.
    Oh T; Kim N; Moon Y; Kim MS; Hoehn BD; Park CH; Kim TS; Kim NK; Chung HC; An S
    J Mol Diagn; 2013 Jul; 15(4):498-507. PubMed ID: 23747112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Free DNA and carcinoembryonic antigen serum levels: an important combination for diagnosis of colorectal cancer.
    Flamini E; Mercatali L; Nanni O; Calistri D; Nunziatini R; Zoli W; Rosetti P; Gardini N; Lattuneddu A; Verdecchia GM; Amadori D
    Clin Cancer Res; 2006 Dec; 12(23):6985-8. PubMed ID: 17145818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum sAPRIL: a potential tumor-associated biomarker to colorectal cancer.
    Ding W; Wang J; Wang F; Wang G; Wu Q; Ju S; Cong H; Wang H
    Clin Biochem; 2013 Oct; 46(15):1590-4. PubMed ID: 23792260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating nucleosomes as new blood-based biomarkers for detection of colorectal cancer.
    Rahier JF; Druez A; Faugeras L; Martinet JP; Géhénot M; Josseaux E; Herzog M; Micallef J; George F; Delos M; De Ronde T; Badaoui A; D'Hondt L
    Clin Epigenetics; 2017; 9():53. PubMed ID: 28515797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating Levels of Adipocytokines as Potential Biomarkers for Early Detection of Colorectal Carcinoma in Egyptian Patients.
    Zekri AR; Bakr YM; Ezzat MM; Zakaria MS; Elbaz TM
    Asian Pac J Cancer Prev; 2015; 16(16):6923-8. PubMed ID: 26514469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of DNA methylation in bowel lavage fluid for detection of colorectal cancer.
    Harada T; Yamamoto E; Yamano HO; Nojima M; Maruyama R; Kumegawa K; Ashida M; Yoshikawa K; Kimura T; Harada E; Takagi R; Tanaka Y; Aoki H; Nishizono M; Nakaoka M; Tsuyada A; Niinuma T; Kai M; Shimoda K; Shinomura Y; Sugai T; Imai K; Suzuki H
    Cancer Prev Res (Phila); 2014 Oct; 7(10):1002-10. PubMed ID: 25139296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-translational histone modifications in circulating nucleosomes as new biomarkers in colorectal cancer.
    Gezer U; Holdenrieder S
    In Vivo; 2014; 28(3):287-92. PubMed ID: 24815828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of autoantibody signatures as biomarkers for early detection of colorectal carcinoma.
    Chang W; Wu L; Cao F; Liu Y; Ma L; Wang M; Zhao D; Li P; Zhang Q; Tan X; Yu Y; Lou Z; Zhao J; Zhang H; Fu C; Cao G
    Clin Cancer Res; 2011 Sep; 17(17):5715-24. PubMed ID: 21771877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An integrated proteomics and metabolomics approach for defining oncofetal biomarkers in the colorectal cancer.
    Ma Y; Zhang P; Wang F; Liu W; Yang J; Qin H
    Ann Surg; 2012 Apr; 255(4):720-30. PubMed ID: 22395091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normal and modified urinary nucleosides represent novel biomarkers for colorectal cancer diagnosis and surgery monitoring.
    Feng B; Zheng MH; Zheng YF; Lu AG; Li JW; Wang ML; Ma JJ; Xu GW; Liu BY; Zhu ZG
    J Gastroenterol Hepatol; 2005 Dec; 20(12):1913-9. PubMed ID: 16336453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone Methylation Marks on Circulating Nucleosomes as Novel Blood-Based Biomarker in Colorectal Cancer.
    Gezer U; Yörüker EE; Keskin M; Kulle CB; Dharuman Y; Holdenrieder S
    Int J Mol Sci; 2015 Dec; 16(12):29654-62. PubMed ID: 26690425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum concentrations of brain-derived neurotrophic factor (BDNF) are decreased in colorectal cancer patients.
    Brierley GV; Priebe IK; Purins L; Fung KY; Tabor B; Lockett T; Nice E; Gibbs P; Tie J; McMurrick P; Moore J; Ruszkiewicz A; Burgess A; Cosgrove LJ
    Cancer Biomark; 2013; 13(2):67-73. PubMed ID: 23838134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased DNA integrity in colorectal cancer.
    Leszinski G; Lehner J; Gezer U; Holdenrieder S
    In Vivo; 2014; 28(3):299-303. PubMed ID: 24815830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated serum synuclein-gamma in patients with gastrointestinal and esophageal carcinomas.
    Liu C; Ma H; Qu L; Wu J; Meng L; Shou C
    Hepatogastroenterology; 2012 Oct; 59(119):2222-7. PubMed ID: 22440249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Saliva and plasma TIMP-1 in patients with colorectal cancer: a prospective study.
    Holten-Andersen L; Christensen IJ; Jensen SB; Reibel J; Laurberg S; Nauntofte B; Brünner N; Nielsen HJ
    Scand J Gastroenterol; 2012 Oct; 47(10):1234-41. PubMed ID: 22871105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alu-based cell-free DNA: a potential complementary biomarker for diagnosis of colorectal cancer.
    Qi J; Qian C; Shi W; Wu X; Jing R; Zhang L; Wang Z; Ju S
    Clin Biochem; 2013 Jan; 46(1-2):64-9. PubMed ID: 22975639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel methylation panel for the early detection of colorectal tumors in stool DNA.
    Azuara D; Rodriguez-Moranta F; de Oca J; Soriano-Izquierdo A; Mora J; Guardiola J; Biondo S; Blanco I; Peinado MA; Moreno V; Esteller M; Capellá G
    Clin Colorectal Cancer; 2010 Jul; 9(3):168-76. PubMed ID: 20643622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of aberrant p16 methylation in the serum of colorectal cancer patients.
    Zou HZ; Yu BM; Wang ZW; Sun JY; Cang H; Gao F; Li DH; Zhao R; Feng GG; Yi J
    Clin Cancer Res; 2002 Jan; 8(1):188-91. PubMed ID: 11801557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant methylation of APC, MGMT, RASSF2A, and Wif-1 genes in plasma as a biomarker for early detection of colorectal cancer.
    Lee BB; Lee EJ; Jung EH; Chun HK; Chang DK; Song SY; Park J; Kim DH
    Clin Cancer Res; 2009 Oct; 15(19):6185-91. PubMed ID: 19773381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.